These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6314546)

  • 61. [Treatment of angina pectoris with 3-phenyl 4-diethylaminoethyl 5-imino 1,2,4-oxadizole(chlorhydrate). Apropos of 30 cases].
    Blum J; Gallet M; Tourniaire A
    Lyon Med; 1967 Dec; 218(50):1537-58. PubMed ID: 5587129
    [No Abstract]   [Full Text] [Related]  

  • 62. [Experience with new psychostimulant - Sydnocarb].
    Bach O; Petermann H; Heber I
    Psychiatr Neurol Med Psychol (Leipz); 1976 Oct; 28(10):609-14. PubMed ID: 798218
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effects of Imolamin on hemodynamics and pacing induced angina pectoris (author's transl)].
    Leisch F; Bergmann H; Schützenberger W; Herbinger W
    Wien Med Wochenschr; 1980 Sep; 130(18):606-8. PubMed ID: 7008372
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Cellular mechanism of action of molsidomine. Bioinduction of prostacyclin].
    Poincelot B; Russo-Marie F
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):535-7. PubMed ID: 6421223
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Experience with the use of sidnocarb in child psychiatry].
    Linka Z
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):278-80. PubMed ID: 1119270
    [No Abstract]   [Full Text] [Related]  

  • 66. [Sydnocarb as the method of choice in persistent enuresis? Findings after 2 years of administration].
    Simlová M; Vocásek Z
    Cesk Psychiatr; 1985 Oct; 81(5):312-3. PubMed ID: 4064147
    [No Abstract]   [Full Text] [Related]  

  • 67. [Comparative characteristics of the antihypoxic efficacy of pharmacologic preparations and barochamber training in man].
    Kovalenko EA; Katkov AIu; Popkov VL; Bobrovnitskiĭ MP; Chabdarova RN
    Fiziol Cheloveka; 1985; 11(5):808-13. PubMed ID: 4076660
    [No Abstract]   [Full Text] [Related]  

  • 68. [Coronary insufficiency. Biological and clinical update. The value of sydnonimines. International symposium. Lyons, 2-3 October 1987. Proceedings].
    Presse Med; 1988 May; 17(20):979-1048. PubMed ID: 2969102
    [No Abstract]   [Full Text] [Related]  

  • 69. [An assessment of the antianginous and metabolic effects of imolamine (author's transl)].
    Fabián J; Brodan V; Spácil J; Widimský J
    Cas Lek Cesk; 1980 May; 119(20-21):584-8. PubMed ID: 7407828
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effect of sidnocarb and dihydroergotamine during 6-hour head-down tilt hypokinesia on human physical work capacity].
    Anashkin OD; Amel'kina GV; Modin AIu
    Kosm Biol Aviakosm Med; 1983; 17(2):93-5. PubMed ID: 6855181
    [No Abstract]   [Full Text] [Related]  

  • 71. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of korvatone on hemodynamics in the acute stage of myocardial infarct].
    Belov Iu; Daskalov T; Chichovski K; Kusitasev G; Popnikolov S
    Vutr Boles; 1981; 20(5):70-80. PubMed ID: 6895680
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Activity of propaxoline in some spastic conditions].
    Mainieri L; Franceschini MC
    Minerva Med; 1969 Jan; 60(9):340-8. PubMed ID: 5766394
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of molsidomine, an anti-anginal drug, on arachidonic acid metabolism in human platelets.
    Croset M; Lagarde M
    Biomed Biochim Acta; 1984; 43(8-9):S354-7. PubMed ID: 6440549
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Therapeutic effectiveness of molsidomine in patients with exercise-induced angina pectoris].
    Sinkiewicz W; Dziedziczko A
    Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):80-2. PubMed ID: 8361895
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].
    Metelitsa VI; Martsevich SIu; Kozyreva MP; Slastnikova ID; Vakulovskaia MK
    Eksp Klin Farmakol; 1994; 57(3):47-50. PubMed ID: 7914121
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Drugs to prevent recurrence of urinary bladder tumors; preventive and curative drugs in chronic stenocardia].
    Shimizu M
    Kango; 1972 Apr; 24(4):91-4. PubMed ID: 4482738
    [No Abstract]   [Full Text] [Related]  

  • 79. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hemodynamic effect of molsidomine in acute administration and as a long-term medication].
    Osterspey A; Jansen W; Tauchert M; Schell U; Fuchs M; Hombach V; Hilger HH
    Med Welt; 1983 Apr; 34(17):523-8. PubMed ID: 6408341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.